Dr. Jeremy Li Agostinho, MD

Dr. Agostinho practices at Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health.

Dr. Agostinho's NPI, 1346602018, was assigned on March 22, 2016. Dr. Agostinho holds Pennsylvania license MD468112.

Dr. Agostinho's primary practice is Geisinger Medical Center, at 100 North Academy Avenue, Danville, PA 17822 in Montour County. The practice phone is (570) 271-6211.

Dr. Agostinho's primary practice is Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health. Dr. Agostinho is also affiliated with Geisinger Wyoming Valley Medical Center. The medical group on file is Geisinger. Dmand AI also links Dr. Agostinho to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agostinho practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Agostinho's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Agostinho is licensed in Pennsylvania.

CMS data shows 769 Medicare services from Dr. Agostinho across 9 procedure codes in 2024, for 343 Medicare patients. Medicare paid $58,567 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 343 Medicare patients who saw Dr. Agostinho in 2024. The largest group is 75 to 84, with 114 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 3.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agostinho's median patient age at 70, with 40% women.

In 2024, Dr. Agostinho wrote 345 Medicare Part D claims for 70 patients. 93% of them were for generic drugs. CMS names the drug for 232 of them, across 11 drugs with 11 or more claims each, at $23,490 in total drug cost. In 2023, CMS named 137 claims across 9 drugs.

Dr. Agostinho accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agostinho as offering telehealth.

Dmand AI links 1 paper to Dr. Agostinho in 2018. Dr. Agostinho's most frequent co-author is Olga Karasik, MD.

CMS Open Payments shows 2 general payments to Dr. Agostinho from 1 drug or device company from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $190.